
Labcorp launches blood test to accelerate Alzheimer’s diagnosis
Dive Brief: Labcorp is now offering a blood-based biomarker test in the U.S. to support the diagnosis of Alzheimer's disease. The immunoassay measures the ratio of ptau-217 and beta amyloid 42, two distinct biomarkers of Alzheimer's, according to …